Suchergebnisse - "Yoshikawa, Naoyuki"

PubPharm (7)

1

Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan

enthalten in: Scientific reports | 2021

von Nakano, Y. | Kurano, M. | Morita, Y. | +14

2

Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan

enthalten in: PloS one | 2021

von Yokoyama, R. | Kurano, M. | Morita, Y. | +14

3

Autotaxin and soluble IL-2 receptor concentrations in cerebrospinal fluids are useful for the diagnosis of central nervous system invasion caused by haematological malignancies

enthalten in: Annals of clinical biochemistry | 2019

von Shimura, T. | Kurano, M. | Morita, Y. | +6

4

Isoprenoid geranylgeranylacetone inhibits human colon cancer cells through induction of apoptosis and cell cycle arrest

enthalten in: Anti-cancer drugs | 2010

von Yoshikawa, N. | Tsuno, N. | Okaji, Y. | +5

5

Id1/Id3 knockdown inhibits metastatic potential of pancreatic cancer

enthalten in: The Journal of surgical research | 2010

von Shuno, Y. | Tsuno, N. | Okaji, Y. | +12

6

Plaunotol and geranylgeraniol induce caspase-mediated apoptosis in colon cancer

enthalten in: The Journal of surgical research | 2009

von Yoshikawa, N. | Yamada, J. | Tsuno, N. | +10

7

Pilot study of anti-angiogenic vaccine using fixed whole endothelium in patients with progressive malignancy after failure of conventional therapy

enthalten in: European journal of cancer (Oxford, England : 1990) | 2008

von Okaji, Y. | Tsuno, N. | Tanaka, M. | +15

1
[1]